Karen Prange latest transaction was an Uninformative Buy of ―.
What was Karen Prange's most profitable transaction?
Karen Prange’s most profitable transaction was an Informative Sell of ATRC stock on June 12, 2023. The return on the trade was 53.20%.
What is Karen Prange's role in Boston Scientific?
Karen Prange's role in Boston Scientific is SVP&Pres, Uro & Pelvic Health.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.